Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis
Background: The addition of caplacizumab to immune thrombotic thrombocytopenia (iTTP) treatment options has led to a renewed interest in characterizing the epidemiology and risk factors for bleeding in iTTP. Limited data exist on the bleeding risk in iTTP due to systemic underreporting in earlier co...
Saved in:
| Main Authors: | Amir A. Mahmoud, Mariam Mostafa, Ali Abdelhay, Mouhamed Yazan Abou-Ismail, Shruti Chaturvedi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924003492 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)
by: Mihaela-Sabrina HERDEA, et al.
Published: (2025-03-01) -
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Research in context
by: Paul Coppo, et al.
Published: (2025-04-01) -
Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report
by: Judith Schimpf, et al.
Published: (2025-04-01) -
Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab
by: Tadafumi Yokoyama, et al.
Published: (2024-12-01) -
Púrpura trombótica trombocitopénica: importancia del trabajo multidisciplinar
by: Angel Orera, et al.
Published: (2025-07-01)